Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cutaneous T-cell lymphoma stage III
ADR ID BADD_A09757
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.03      Mycoses fungoides
01.11.03.007      Cutaneous T-cell lymphoma stage III
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.03      Mycoses fungoides
16.17.03.007      Cutaneous T-cell lymphoma stage III
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.04      Skin and subcutaneous conditions NEC
23.07.04.034      Cutaneous T-cell lymphoma stage III
Description Not Available
MedDRA Code 10011682
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cerebriform T lymphoma (Lukes-Collins Classification) stage III | Cutaneous T-cell lymphoma stage III | Mycosis fungoides (Working Formulation) stage III | Mycosis fungoides stage III | Mycosis fungoides/Sezary syndrome stage III | Sezary syndrome stage III | Sezary's disease stage III | Sezary's syndrome stage III | Small cell cerebriform (Mycosis fungoides sezary syndrome) (Kiel Classification) stage III
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01083Hydrochlorothiazide0.000010%
The 1th Page    1    Total 1 Pages